Syncytiotrophoblast differentiation defects drive ER stress and reprogram placental PSG1 glycosylation in preeclampsia
During pregnancy, placenta-derived proteins such as pregnancy-specific glycoprotein 1 (PSG1) enter the maternal circulation, providing a window into placental health and enabling liquid biopsy strategies for monitoring pregnancy disorders. PSG1, a highly glycosylated protein secreted by syncytiotrophoblast (STB) cells, reflects trophoblast differentiation status. Circulating PSG1 levels are reduced in early-onset preeclampsia (PE), but how PSG1 glycosylation is altered in this condition remains unclear. Here, we show by liquid chromatography-tandem mass spectrometry that native PSG1 purified from healthy and early-onset PE pregnancies carries an O-linked glycan in its N domain in addition to diverse N-linked glycans. In PE, PSG1 N-glycans displayed a shift toward increased oligomannose structures and reduced sialylation. Induction of endoplasmic reticulum (ER) stress in primary STBs altered the glycosylation enzyme machinery, and single-nucleus transcriptomic data indicated a reduced contribution of mature STB populations in PE, consistent with an immature STB-like glycoprotein signature. Altered N-glycosylation increased binding to mannose and asialoglycoprotein receptors and cellular uptake, suggesting enhanced hepatic clearance as a possible explanation for reduced circulating PSG1 levels in PE. Our data link ER stress during STB differentiation to altered glycoprotein maturation and identify PSG1 glycosylation as a readout of a stress-impaired STB in PE. Glycan features of circulating placental proteins could therefore provide information beyond protein levels alone and complement liquid biopsy approaches.
Authors
- Marc Ferrer (ORCID: https://orcid.org/0000-0003-4569-9137)
- Nándor Gábor Than (ORCID: https://orcid.org/0000-0001-9385-7019)
- Julia Baumeister (ORCID: https://orcid.org/0009-0002-8049-0566)
- Charlotte Harms (ORCID: https://orcid.org/0000-0002-5105-4020)
- Gabriela S. Dveksler (ORCID: https://orcid.org/0000-0003-3037-1155)
- Sandra M. Blois (ORCID: https://orcid.org/0000-0002-0434-2660)
- Jennifer J. Hill (ORCID: https://orcid.org/0000-0002-5550-8173)
- Florian Herse (ORCID: https://orcid.org/0000-0002-9305-8134)
- Stefan Verlohren (ORCID: https://orcid.org/0000-0003-3507-8636)
- Alexandra Gellhaus (ORCID: https://orcid.org/0000-0001-9506-4581)
- Yiru Wang (ORCID: https://orcid.org/0000-0001-7542-8392)
- Cristina Antich (ORCID: https://orcid.org/0000-0001-7511-0480)
- Fabian Higel (ORCID: https://orcid.org/0009-0006-5966-1294)
- James Warren (ORCID: https://orcid.org/0000-0002-6290-2785)
- Mariana G. Garcia
Institutions
- Semmelweis University (HU)
- National Institutes of Health (US)
- Boehringer Ingelheim (Germany) (DE)
- Uniformed Services University of the Health Sciences (US)
- Universität Hamburg (DE)
- Max Delbrück Center (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- National Center for Advancing Translational Sciences (US)
- Institute of Molecular Life Sciences (HU)
- National Research Council Canada (CA)
- Ottawa Institute of Systems Biology (CA)
- University of Duisburg-Essen (DE)
- Charité - Universitätsmedizin Berlin (DE)
- HUN-REN Research Centre for Natural Sciences (HU)
Publication Details
- Journal
- Molecular Biomedicine
- Published
- 2026-10-30
- DOI
- https://doi.org/10.1186/s43556-026-00634-x
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- National Institute of Nursing Research